Eli Lilly continues major contribution to Australian diabetes research and education
Tuesday 5 September, 2006: More than $170,000 in research grants have been announced at the Australian Diabetes Society Conference (23rd - 25th August), as part of Eli Lilly's ongoing commitment to diabetes care in Australia.
The Eli Lilly Diabetes Research Grants program provides support for the Australian Diabetes Society grant for independent health professional research into the understanding or treatment of patients with diabetes mellitus (totaling $150,000) as well as the Australian Diabetes Educators Association (ADEA's) grant for diabetes nurse educators on projects which have a patient education or clinical focus (totaling $20,000).
"Grant programs are crucial because they support research that allows us to learn more about the causes of and treatments for diabetes," said the Chair of the Eli Lilly review panel, Dr Alicia Jenkins, St Vincent's Hospital, Melbourne.
"It is particularly pleasing to have available a substantial grant for a new investigator. Such assistance at an early stage of their career is vital for retaining talented young researchers in the field of diabetes."
The Australian Diabetes Society grant includes $30,000 for the New Investigator Award which is given to a researcher who has not previously received a research grant from any source. This year's recipient of the Eli Lilly Diabetes Research Grant New Investigator award will be awarded to Dr Antonia Miller from the University of Melbourne.
General Awards - up to $40,000 each from a total pool of $120,000 - will be presented to Associate Prof Chen Chen from Prince Henry's Institute of Medical Research, Dr Kenneth Wai Kheong Ho from The Garvan Institute of Medical Research, Associate Prof Darren Kelly from St Vincent's Hospital and Dr Paul Witting from the Concord Repatriation Hospital.
Recipients of the Australian Diabetes Educators Association grant are; Ms Carmel Smart, Hunter Children's Health Network and the team of Ms Dianne Roberts and Ms Wendy Mossman, Diabetes Health Service.
"The Diabetes Research Grant Program is part of Eli Lilly's long term commitment to understanding diabetes mellitus while also helping to support and fund independent Australian diabetes research," said Managing Director of Eli Lilly Australia, Stephen Fry.
"Eli Lilly's commitment has extended to the contribution of $1.42 million to support independent research into diabetes since 2000.
"Diabetes is a chronic, debilitating and sometimes fatal condition that impacts more than five percent of Australians. It is important that we recognise the contribution of those people in the community who work tirelessly to reduce the impact of diabetes on the lives of others," said Mr Fry.
Lilly's Leadership in Diabetes
Through a long-standing commitment to diabetes care, Lilly provides patients with breakthrough treatments that enable them to live longer, healthier and fuller lives. Since 1923, Lilly has been the industry leader in pioneering therapies to help health care professionals improve the lives of people with diabetes, and research continues on innovative medicines to address the unmet needs of patients.
About Eli Lilly and Company
In Australia, Lilly is a leading research-driven pharmaceutical company, specialising in discovery, development and marketing of medicines for prevention and treatment of human disease.
Lilly's pipeline is one of the strongest in the industry and has the potential to address many serious unmet medical needs of people worldwide. In the last decade, Lilly has introduced important new drugs for the treatment of cancer, schizophrenia, osteoporosis, diabetes, cardiovascular complications and most recently severe sepsis.
Lilly supports research and development in Australia through alliances with some of the country's foremost biotechnology companies, medical research institutions and universities.
# # #
Issued on behalf of the Eli Lilly Diabetes Research Grant Program.
For further information contact Gareth Finch (0409 747 157) or Karina Candia (0402 307 056) at Palin Communications 02 9420 1387.
Last Updated: Wednesday November 05, 2014 21:27:32
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.
This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents.
© Children with Diabetes, Inc. 1995-2016. Comments and Feedback.